Trial Profile
Recombinant Human Endostatin (Endostar) Combined With Concurrent Chemoradiotherapy for Advanced Non-small Cell Lung Cancer: A Multicenter, Randomized, Controlled Trial
Status:
Not yet recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Endostatin (Primary) ; Etoposide (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 20 Jul 2018 New trial record